Page 3 - Preference Management Solution News Today

The level of clinical research in Africa remains very low in proportion to population size, despite an increase in trial activity.

Dragonfly Therapeutics and AbbVie expanded their partnership to develop immunotherapies for new targets in fibrotic and autoimmune diseases.

AstraZeneca has reported that its Evusheld offered protection against symptomatic Covid-19 for a minimum of six months in Phase III trial.

Veru has reported interim analysis data from a Phase III trial, where sabizabulin lowered mortality by 55% in hospitalised Covid-19 patients.

EXCLUSIVE: Clinical Trials Arena analysed tens of thousands of official records to find out which companies are at the bottom of the ranks.

Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.

Tiziana Life Sciences has commenced a Phase Ib trial of oral enteric-coated capsules of foralumab for treating Crohn’s disease patients.

Pfizer has announced that the company will not commence any new clinical trials in Russia amid the Ukraine crisis.

Russia is dependent on Taiwan's semiconductors for everything from the manufacture of laptops to military equipment.

DiscGenics has reported positive interim results from its Phase I/II trial of IDCT (rebonuputemcel) to treat degenerative disc disease.